Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Tags Social issues Healthy Returns Regeneron Pharmaceuticals Inc
From CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Tags Companies Hims & Hers Health Inc US: News
From CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Tags Health & Science Gilead Sciences Inc Pfizer Inc
From CNBC.com News
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Tags Social issues Amgen Inc Healthy Returns
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Novo Nordisk A/S Investing Markets
From CNBC.com News
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Tags Business News Breaking News: Business Biotechnology
From CNBC.com News
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Tags Social issues Healthy Returns Health & Science
From CNBC.com News
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Tags Health Insurance Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Tags Health care industry Novo Nordisk A/S Biotechnology
From CNBC.com News
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
Tags Novo Nordisk A/S Breaking News: Europe Europe News
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags Breaking News: Politics Novo Nordisk A/S GSK plc
From CNBC.com News
Why Americans pay so much more for prescription drugs
Tags LILLY DRN Politics Drug Retail
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags Social issues CVS Health Corp LILLY DRN
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags LILLY DRN Roche Holding AG Business News
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Make It: Next Gen Investing Hims & Hers Health Inc Make It
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Enterprise Technology Breaking News: Technology
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags Cloudflare Inc Investment Strategy Advanced Micro Devices Inc
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Novo Nordisk A/S Biotechnology Pharmaceuticals
From CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Tags Health care industry Biotechnology Novo Nordisk A/S
From CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
Tags Companies Hims & Hers Health Inc Business
From CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Tags Breaking News: Business LILLY DRN Business News
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Healthy Returns Social issues Elevance Health Inc
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags LVMH Moet Hennessy Louis Vuitton SE Europe News Europe Markets
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Business US: News Structure Therapeutics Inc
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags Market Outlook World Markets JPMorgan Chase & Co
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags Health & Science Biotech and Pharmaceuticals Companies
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Europe News Business Breaking News: Economy
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags US: News Business Social issues
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags Brunello Cucinelli SpA Standard Chartered PLC AstraZeneca PLC
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Pharmaceuticals Biotech and Pharmaceuticals Trade
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.